Sage Therapeutics Inc (SAGE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SAGE.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
SAGE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The percent of analysts bearish on the stock of SAGE is lower than just about 100% of all US stocks.
- The number of analysts covering the stock of SAGE is higher than 98.64% of stocks in the mid market cap category.
- The variance in analysts' estimates of SAGE is less than 1.59999999999999% of stocks in the mid market cap category.
- The average analyst price target of SAGE is greater than 90.85% of Pharmaceutical Products stocks.
- SAGE has a higher upside potential (average analyst target price relative to current price) than 88.23% of stocks in the mid market cap category.
- Sage Therapeutics Inc's percentage of analysts bullish on the stock is higher than 27.65% of Pharmaceutical Products stocks.
- SAGE has a less change in bullishness amongst analysts than just about 100% of all US stocks.
Make investment decisions regarding SAGE using the data that counts. Try POWR Ratings for free.